Financial results - MIS PHARM RESEARCH S.R.L.

Financial Summary - Mis Pharm Research S.r.l.
Unique identification code: 47993490
Registration number: J40/7166/2023
Nace: 7219
Sales - Ron
197.123
Net Profit - Ron
122.745
Employee
1
The most important financial indicators for the company Mis Pharm Research S.r.l. - Unique Identification Number 47993490: sales in 2024 was 197.123 euro, registering a net profit of 122.745 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron19K197K2023202320242024

Sales, Profit, Employees, Debts, Capitals, Financial Results - Mis Pharm Research S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - - 18.559 197.123
Total Income - EUR - - - - - - - - 18.650 199.225
Total Expenses - EUR - - - - - - - - 7.029 74.548
Gross Profit/Loss - EUR - - - - - - - - 11.620 124.677
Net Profit/Loss - EUR - - - - - - - - 11.438 122.745
Employees - - - - - - - - 1 1
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales increased by 114.7%, from 18.559 euro in the year 2023, to 197.123 euro in 2024. The Net Profit increased by 66.166 euro, from 11.438 euro in 2023, to 122.745 in the last year.
Sales - Ron19K197K2023202320242024
Net Profit - Ron11K123K2023202320242024
Employees112023202320242024

Check the financial reports for the company - Mis Pharm Research S.r.l.

Rating financiar

Financial Rating -
Mis Pharm Research S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Mis Pharm Research S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Mis Pharm Research S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Mis Pharm Research S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Mis Pharm Research S.r.l. - CUI 47993490

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - - 974 4.411
Current Assets - - - - - - - - 11.358 123.465
Inventories - - - - - - - - 0 0
Receivables - - - - - - - - 9.740 94.711
Cash - - - - - - - - 1.618 28.754
Shareholders Funds - - - - - - - - 11.479 122.985
Social Capital - - - - - - - - 40 200
Debts - - - - - - - - 853 5.255
Income in Advance - - - - - - - - 0 0
Exchange rate - RON 1 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7219 - 7219"
CAEN Financial Year 7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 123.465 euro in 2024 which includes Inventories of 0 euro, Receivables of 94.711 euro and cash availability of 28.754 euro.
The company's Equity was valued at 122.985 euro, while total Liabilities amounted to 5.255 euro. Equity increased by 66.206 euro, from 11.479 euro in 2023, to 122.985 in 2024.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Mis Pharm Research S.r.l.

Review
0.00
(0 reviews)
5 stars
(0)
4 stars
(0)
3 stars
(0)
2 stars
(0)
1 star
(0)

Comments - Mis Pharm Research S.r.l.

Similar services useful for checking companies and business development.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.